Shuang Liu

Biography

Dr. Liu graduated with his Ph.D. in 1990 from Memorial University of Newfoundland, Canada. He spent the next three years as a postdoctoral fellow at the University of British Columbia. After nine years of industrial research at DuPont Medical Imaging Division (now Lantheus Medical Imaging Inc.), he joined Purdue University as Associate Professor in 2002, and then became a full professor in School of Health Sciences. Dr. Liu is the leader in using radiolabeled multimeric RGD peptides as radiotracers for non-invasive imaging of integrin αvβ3 expression in the rapidly growing and metastatic tumors. After evaluating >30 radiotracers in different tumor-bearing animal models, 99mTc-3P-RGD2 has been selected for clinical evaluation. Clinical data clearly indicate that 99mTc-3P-RGD2 is very useful for the diagnosis of primary tumors (breast, esophagus, head & neck, lung, and melanoma) and small metastatic lesions in breast cancer patients.

Research Interest

Development of new target-specific radiotracers for early diagnosis of cancer Development of new techniques for the radiolabeling of small biomolecules Evaluation of cationic metal complexes as radiotracers for cardiac perfusion imaging Fundamental coordination chemistry of radiopharmaceuticals